论文信息 - Effectiveness of Nivolumab in Second-Line and Later in Patients with Advanced Non-Small Cell Lung Cancer in Real-Life Practice in France and Germany: Analysis of the ESME-AMLC and CRISP Cohorts - 字舞流文

Effectiveness of Nivolumab in Second-Line and Later in Patients with Advanced Non-Small Cell Lung Cancer in Real-Life Practice in France and Germany: Analysis of the ESME-AMLC and CRISP Cohorts

I. Durand-zaleski | J. Penrod | F. Cotté | C. Audigier-Valette | F. Griesinger | M. Daumont | L. Lacoin | D. Debieuvre | L. Bosquet | C. Chouaid | S. Zacharias | A. Fleitz | Michael Thomas | A. Calleja | D. Waldenberger | Annika Groth | Sonya Patel | R. Carroll